|
A review of the device history records was performed for the indicated packaging and component lots for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly and performance specifications.The (b)(6) 2016 angiodynamics complaint report was reviewed for the xcela picc w/pasv product family and the failure mode "leakage - valve / blood back-up." no adverse trend was identified.As received, the catheter was contaminated with bio matter inside and out.The valves were visualized microscopically, and the valves discs were confirmed to be slit and centered.There were no molding/manufacturing related non-conformances noted to the returned sample, nor were kinks, compressions or other damage noted.During the cleaning process a 10ml syringe was used to infuse the cleaning solution through the valve and through the catheter.Infusion could not be performed due to the bio matter {dried blood}.The sample was soaked in the cleaning solution (bleach and warm water mixture), after which the bio matter was able to be removed.A guidewire (0.018") was inserted through the lumens of the returned sample without difficulty, confirming patency.The infusion and aspiration pressures were measured on each valve, per angiodynamics procedures, and were found to meet specification.The tip of the catheter was cross-sectioned and did not show any thin spots.The tubing id, od, and thickness of the septum wall and tubing wall were measured and met specification.The reported complaint description could not be confirmed for valve leaking, as the returned used sample was evaluated and found to be visually and functionally acceptable, i.E.Met specification.A definitive root cause for this incident could not be determined but potential contributing factors may include the end user not securing the end cap during routine maintenance, catheter care as described in the directions for use.(b)(4).
|